-5%
Highnoon Labs
Genthro 500mg Tablets 6s
20 Tablets
Rated 4.5 out of 5 (49)
Rs. 1,275Rs. 1,340
In Stock
-8%Rx only
ICI
Diabetron CR 30mg Tablets 30s
Rated 3.5 out of 5 (33)SKU HP-05734
A tablet containing Gliclazide, indicated for Diabetes.
Rs. 1,620Rs. 1,760-8%
You save Rs. 140
100ml Syrup
In StockSet your city for an exact delivery date
In stock at selected branches
Prescription required
A licensed pharmacist will verify your prescription and call you within 15 minutes before this is dispensed.
Upload your prescriptionQuantity
Diabetron CR 30mg Tablets 30s quantity: 1
- 100% authentic
- Free over Rs. 1,500
- Pharmacist verified
- 7-day returns
Total for 1 pack: Rs. 1,620
What it is used for: Diabetes.
Indications as listed by the manufacturer: It is used to control blood glucose (sugar) in patients with Type II diabetes mellitus.
How it works: It is used when diet and exercise are not enough to control your blood glucose properly. It lowers blood glucose by increasing the amount of insulin (a hormone that controls blood glucose levels) produced by your pancreas.
Active ingredient: Gliclazide.
Reported side effects: Gastro-intestinal: Abdominal pain, anal fissure, appetite increased, colitis, duodenal ulcer, epigastric fullness, faecal incontinence, flatulence, gastric irritation, gastroesophageal reflux, GI neoplasm benign, hemorrhoids, melena, dry mouth, oesophagitis, saliva increased, tooth ache, tooth disorder, vomiting. These reactions are generally dose-related and may disappear when the dose is reduced. Hearing and vestibular: hearing decreased, tinnitus. Liver and biliary: increased liver enzymes, hepatitis, hepatomegaly. Metabolic and nutritional: gout, glycosuria, hypercholesterolemia, hypertriglyceridemia, thirst. Cases of hepatic porphyria and disulfiram-like reactions have been described with sulfonylurea drugs. Clinical experience to date has shown that gliclazide 80 mg tablets has a low incidence of disulfiram type reactions. Musculo-skeletal: arthropathy, bursitis, hernia congenital, skeletal pain, spine malformation.
Known drug interactions: Long-acting sulfonamides, tuberculostatics, NSAIDs, fibrates, monoamine oxidase inhibitors, salicylates, probenecid, beta-blockers, azole antifungal agents (oral and parenteral preparations), H2 receptor antagonists and angiotensin converting enzyme inhibitors , other antidiabetic agents (insulin, alpha glucosidase inhibitors, biguanides) , diuretics (thiazides, furosemide), corticosteroids, oral contraceptives (estrogen plus progestogen), chlorpromazine, ritodrine, salbutamol, terbutaline and nicotinic acid , Miconazole , Phenylbutazone , MAOIs , Chlorpromazine (neuroleptic agent) .
- Sourced through authorised distributors and checked against batch and expiry on arrival
- Dispensed by a registered pharmacist from our DRAP-licensed branches
- Free pharmacist advice on interactions and timing — call or ask at checkout
- Same-day delivery in Karachi, Lahore and Islamabad on orders placed before 6pm
Maturity-onset diabetes : Adults : 40-80mg daily increasing if necessary to max 320mg daily. Doses above 160mg should be taken in two divided doses. Type 2 diabetes : Adults : 30-120mg depending on response, once daily with breakfast, including eldrely or those with renal failure. Children : Not recommended. OR As directed by your physician.
Follow your doctor’s instructions. The dosage above is the usual range — your prescription takes precedence over it.
Active ingredient: Gliclazide. Labelled strength: 30mg.
- Do not take if • You are allergic to: gliclazide, or any of the other ingredients • You have had an allergic reaction to any other sulphonylureas, or related medicines such as sulfa antibiotics or to thiazide diuretics (a type of fluid or water tablet).
- Use of gliclazide must be considered as treatment in addition to proper dietary regimen and not as substitute for diet.
- All sulfonylurea drugs can induce severe hypoglycemia. Particularly susceptible are elderly subjects, patients with impaired hepatic or renal function, those who are debilitated or malnourished and patients with primary or secondary adrenal insufficiency. Some cases may be severe and prolonged.
- The efficacy of gliclazide, in reducing glucose to the desired level decreases over a long period of time in many patients: this may be due to progression in the severity of the diabetes, or to a reduced response to treatment. This phenomenon is known as secondary failure and should be distinguished from primary failure, when the drug is ineffective when prescribed as first-line treatment. Adequate dose adjustment and compliance with dietary measures should be considered before classifying the patient as secondary failure. If a loss of adequate blood glucose-lowering response to GLICLAZIDE is detected, the drug should be discontinued.
- In patients stabilized on gliclazide therapy, loss of blood sugar control may occur in cases of acute intercurrent disease or in stressful situations such as trauma or surgery. Under these conditions, discontinuation of gliclazide and administration of insulin should be considered.
Store this medicine at room temperature, away from direct light and heat.
Manufactured by Diabetron Laboratories (Pvt) Ltd.. Country of origin: Switzerland.
3.5
Rated 3.5 out of 533 verified ratings
- 5★0%
- 4★75%
- 3★25%
- 2★0%
- 1★0%
- Sana Malik4 Aug 2026Rated 4.0 out of 5
Good value for the pack size. I compared prices across three sites before ordering.
- Bilal AhmedVerified Purchase22 Jul 2026Rated 4.0 out of 5
Exactly what my doctor prescribed. The pharmacist called to confirm the strength before dispatch, which I appreciated.
- Kamran AliVerified Purchase7 Jul 2026Rated 3.0 out of 5
Fine quality, wrong choice on my part — I should have asked the pharmacist first about the strength.
- Rabia N.Verified Purchase29 Jun 2026Rated 4.0 out of 5
Effective, but it took closer to two months than the four weeks I was hoping for.
Reviews are from verified Hope Pharmacy orders. We do not remove a review for being critical.
What it is used for: Diabetes.
Indications as listed by the manufacturer: It is used to control blood glucose (sugar) in patients with Type II diabetes mellitus.
How it works: It is used when diet and exercise are not enough to control your blood glucose properly. It lowers blood glucose by increasing the amount of insulin (a hormone that controls blood glucose levels) produced by your pancreas.
Active ingredient: Gliclazide.
Reported side effects: Gastro-intestinal: Abdominal pain, anal fissure, appetite increased, colitis, duodenal ulcer, epigastric fullness, faecal incontinence, flatulence, gastric irritation, gastroesophageal reflux, GI neoplasm benign, hemorrhoids, melena, dry mouth, oesophagitis, saliva increased, tooth ache, tooth disorder, vomiting. These reactions are generally dose-related and may disappear when the dose is reduced. Hearing and vestibular: hearing decreased, tinnitus. Liver and biliary: increased liver enzymes, hepatitis, hepatomegaly. Metabolic and nutritional: gout, glycosuria, hypercholesterolemia, hypertriglyceridemia, thirst. Cases of hepatic porphyria and disulfiram-like reactions have been described with sulfonylurea drugs. Clinical experience to date has shown that gliclazide 80 mg tablets has a low incidence of disulfiram type reactions. Musculo-skeletal: arthropathy, bursitis, hernia congenital, skeletal pain, spine malformation.
Known drug interactions: Long-acting sulfonamides, tuberculostatics, NSAIDs, fibrates, monoamine oxidase inhibitors, salicylates, probenecid, beta-blockers, azole antifungal agents (oral and parenteral preparations), H2 receptor antagonists and angiotensin converting enzyme inhibitors , other antidiabetic agents (insulin, alpha glucosidase inhibitors, biguanides) , diuretics (thiazides, furosemide), corticosteroids, oral contraceptives (estrogen plus progestogen), chlorpromazine, ritodrine, salbutamol, terbutaline and nicotinic acid , Miconazole , Phenylbutazone , MAOIs , Chlorpromazine (neuroleptic agent) .
- Sourced through authorised distributors and checked against batch and expiry on arrival
- Dispensed by a registered pharmacist from our DRAP-licensed branches
- Free pharmacist advice on interactions and timing — call or ask at checkout
- Same-day delivery in Karachi, Lahore and Islamabad on orders placed before 6pm
Maturity-onset diabetes : Adults : 40-80mg daily increasing if necessary to max 320mg daily. Doses above 160mg should be taken in two divided doses. Type 2 diabetes : Adults : 30-120mg depending on response, once daily with breakfast, including eldrely or those with renal failure. Children : Not recommended. OR As directed by your physician.
Follow your doctor’s instructions. The dosage above is the usual range — your prescription takes precedence over it.
Active ingredient: Gliclazide. Labelled strength: 30mg.
- Do not take if • You are allergic to: gliclazide, or any of the other ingredients • You have had an allergic reaction to any other sulphonylureas, or related medicines such as sulfa antibiotics or to thiazide diuretics (a type of fluid or water tablet).
- Use of gliclazide must be considered as treatment in addition to proper dietary regimen and not as substitute for diet.
- All sulfonylurea drugs can induce severe hypoglycemia. Particularly susceptible are elderly subjects, patients with impaired hepatic or renal function, those who are debilitated or malnourished and patients with primary or secondary adrenal insufficiency. Some cases may be severe and prolonged.
- The efficacy of gliclazide, in reducing glucose to the desired level decreases over a long period of time in many patients: this may be due to progression in the severity of the diabetes, or to a reduced response to treatment. This phenomenon is known as secondary failure and should be distinguished from primary failure, when the drug is ineffective when prescribed as first-line treatment. Adequate dose adjustment and compliance with dietary measures should be considered before classifying the patient as secondary failure. If a loss of adequate blood glucose-lowering response to GLICLAZIDE is detected, the drug should be discontinued.
- In patients stabilized on gliclazide therapy, loss of blood sugar control may occur in cases of acute intercurrent disease or in stressful situations such as trauma or surgery. Under these conditions, discontinuation of gliclazide and administration of insulin should be considered.
Store this medicine at room temperature, away from direct light and heat.
Manufactured by Diabetron Laboratories (Pvt) Ltd.. Country of origin: Switzerland.
3.5
Rated 3.5 out of 533 verified ratings
- 5★0%
- 4★75%
- 3★25%
- 2★0%
- 1★0%
- Sana Malik4 Aug 2026Rated 4.0 out of 5
Good value for the pack size. I compared prices across three sites before ordering.
- Bilal AhmedVerified Purchase22 Jul 2026Rated 4.0 out of 5
Exactly what my doctor prescribed. The pharmacist called to confirm the strength before dispatch, which I appreciated.
- Kamran AliVerified Purchase7 Jul 2026Rated 3.0 out of 5
Fine quality, wrong choice on my part — I should have asked the pharmacist first about the strength.
- Rabia N.Verified Purchase29 Jun 2026Rated 4.0 out of 5
Effective, but it took closer to two months than the four weeks I was hoping for.
Reviews are from verified Hope Pharmacy orders. We do not remove a review for being critical.
Frequently bought together
ICIDiabetron CR 30mg Tablets 30sRs. 1,620Rated 3.5 out of 5
StandpharmXiga 5mg Tablets 14sRs. 1,595Rated 4.5 out of 5
Martin DowAldactone Tablets 100mg 10sRs. 1,390Rated 4.5 out of 5
Bundle total
Rs. 4,605Rs. 4,990
Information on this site is for general guidance and is not a substitute for professional medical advice. Always consult your doctor or pharmacist.
You might also like
More in Medicine
